Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FV840
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,372
Award facts
- Contract value 100% obligated
- $11,372.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,372.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick on January 28, 2026, with an ultimate completion date of January 29, 2026. This award was made without a set-aside designation on a fully competitive basis. The contract involves delivery of this specialty cardiovascular medication to support federal medical supply needs, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving military and veteran healthcare systems across the federal government.
This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. The parent IDC enables the company to supply a vast range of pharmaceutical products, specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded federal contracts across multiple therapeutic domains demonstrates its established capability to fulfill critical pharmaceutical procurement requirements for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FV840?
SPE2DR26FV840 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FV840 worth?
The government has obligated $11,372 on SPE2DR26FV840.
Is contract SPE2DR26FV840 an order under another contract?
Yes. SPE2DR26FV840 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV840 competed?
The extent of competition for SPE2DR26FV840 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award